Scholars

Summit - (Abingdon, United Kingdom) | Organization

awards grant

A Phase 3, randomized, double-blind, active controlled study to compare the efficacy and safety of ridinilazole (200 mg, bid) for 10 days with vancomycin (125 mg, qid) for 10 days in the treatment of Clostridium difficile infection (CDI). 2020

© Texas A&M University Libraries
|
Terms of Use
|
Powered by VIVO
-
Scholars Discovery